October 2016 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for October 2016. This roundup includes the latest...
Educational Intervention Aids Problematic Hypoglycemia
Nonsignificant reduction in hypoglycemia episodes; significant improvement in hypoglycemia awareness
Weight Gain Impacts 25(OH)D Response in Pregnancy
Among women supplemented with cholecalciferol, season of delivery also influences 25(OH)D level
Oral Probiotics Have No Impact on Vaginal Health in Pregnancy
Similar decrease in proportion of normal vaginal microbiota for treatment, placebo groups
Medicaid Policies Impact Use of Smoking Cessation Medications
Reduction in use with policies that require patients to obtain counseling; use up with increased coverage
Genetic Testing May Help ID VTE Risk in Breast Cancer Patients
Older breast cancer patients with increased genetic susceptibility receiving chemo have highest risk
Tdap Vaccine During Pregnancy Seems Safe for Mother, Infant
Finding should reassure women who get Tdap to help protect their infant against pertussis
Diabetes-Related Distress Ups Risk for Rx Nonadherence
Depression is independent predictor of adherence; reduces the effects of diabetes distress
Low-Dose Isotretinoin Therapeutic for Seborrhea
Significant decrease in rate of sebum production in patients receiving low-dose oral isotretinoin
Few Changes in Employer-Sponsored Insurance 2013-2014
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
